Insider Buy‑Options Surge at Candel Therapeutics: 8 Executives Secure 32K Each, Signaling Strong Future Growth
Insider buys 32,000 zero‑price options at Candel Therapeutics, signaling strong confidence ahead of clinical milestones and potential price gains.
3 minutes to read